The new drug candidate, Paxlovid, significantly reduced hospitalization and death in adult patients, according to Pfizer, and will be submitted for an emergency use authorization in the United States.

Laurent Chapon has been appointed director of the Advanced Photon Source (APS). Chapon will lead the Photon Sciences Directorate at the U.S. Department of Energy’s Argonne National Laboratory through a massive upgrade of the user facility.